186 related articles for article (PubMed ID: 23276558)
1. Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: a potential therapeutic for Alzheimer's disease.
Villaflores OB; Chen YJ; Chen CP; Yeh JM; Wu TY
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):554-64. PubMed ID: 23276558
[TBL] [Abstract][Full Text] [Related]
2. Potential natural products for Alzheimer's disease: targeted search using the internal ribosome entry site of tau and amyloid-β precursor protein.
Tasi YC; Chin TY; Chen YJ; Huang CC; Lee SL; Wu TY
Int J Mol Sci; 2015 Apr; 16(4):8789-810. PubMed ID: 25903151
[TBL] [Abstract][Full Text] [Related]
3. Curcumin Decreases Hyperphosphorylation of Tau by Down-Regulating Caveolin-1/GSK-3β in N2a/APP695swe Cells and APP/PS1 Double Transgenic Alzheimer's Disease Mice.
Sun J; Zhang X; Wang C; Teng Z; Li Y
Am J Chin Med; 2017; 45(8):1667-1682. PubMed ID: 29132216
[TBL] [Abstract][Full Text] [Related]
4. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
[TBL] [Abstract][Full Text] [Related]
5. Curcuminoids and resveratrol as anti-Alzheimer agents.
Villaflores OB; Chen YJ; Chen CP; Yeh JM; Wu TY
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):515-25. PubMed ID: 23276553
[TBL] [Abstract][Full Text] [Related]
6. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
7. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
9. Amantadine as a regulator of internal ribosome entry site.
Chen YJ; Zeng SJ; Hsu JT; Horng JT; Yang HM; Shih SR; Chu YT; Wu TY
Acta Pharmacol Sin; 2008 Nov; 29(11):1327-33. PubMed ID: 18954527
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease.
Lahiri DK; Ge YW; Maloney B
FASEB J; 2005 Apr; 19(6):653-5. PubMed ID: 15703276
[TBL] [Abstract][Full Text] [Related]
11. The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism.
Li M; Pehar M; Liu Y; Bhattacharyya A; Zhang SC; O'Riordan KJ; Burger C; D'Adamio L; Puglielli L
Neurobiol Aging; 2015 Oct; 36(10):2725-36. PubMed ID: 26174856
[TBL] [Abstract][Full Text] [Related]
12. Dual action of memantine in Alzheimer disease: a hypothesis.
Wu TY; Chen CP
Taiwan J Obstet Gynecol; 2009 Sep; 48(3):273-7. PubMed ID: 19797019
[TBL] [Abstract][Full Text] [Related]
13. Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein.
Grimm A; Biliouris EE; Lang UE; Götz J; Mensah-Nyagan AG; Eckert A
Cell Mol Life Sci; 2016 Jan; 73(1):201-15. PubMed ID: 26198711
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine exposure upregulates the amyloid precursor protein and hyperphosphorylated tau expression: The roles of insulin signaling in SH-SY5Y cell line.
Chen L; Zhou L; Yu P; Fang F; Jiang L; Fei J; Xiao H; Wang J
J Toxicol Sci; 2019; 44(7):493-503. PubMed ID: 31270305
[TBL] [Abstract][Full Text] [Related]
15. Anthocyanin-enriched bilberry and blackcurrant extracts modulate amyloid precursor protein processing and alleviate behavioral abnormalities in the APP/PS1 mouse model of Alzheimer's disease.
Vepsäläinen S; Koivisto H; Pekkarinen E; Mäkinen P; Dobson G; McDougall GJ; Stewart D; Haapasalo A; Karjalainen RO; Tanila H; Hiltunen M
J Nutr Biochem; 2013 Jan; 24(1):360-70. PubMed ID: 22995388
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
[TBL] [Abstract][Full Text] [Related]
18. RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activity.
Manczak M; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2368-78. PubMed ID: 24063855
[TBL] [Abstract][Full Text] [Related]
19. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
20. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
